Ina Research Incorporation operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ina Research Incorporation with three other
pharmaceutical manufacturers in Asia:
Malaysian Genomics Resource Centre Berhad
sales of 9.87 million Malaysian Ringgits [US$2.54 million]
Biotoxtech Company Limited
of South Korea
(25.56 billion Korean Won [US$23.95 million]
Scandent Imaging Ltd
based in India
(17.98 million Indian Rupees [US$273,833.04 ]
Ina Research Incorporation reported sales of ¥2.30 billion (US$21.47 million)
March of 2017.
increase of 8.5%
versus 2016, when the company's sales were ¥2.12 billion.
Despite this increase, sales are still
below the level achieved in 2015, when Ina Research Incorporation
reported sales of ¥2.99 billion.
Sales of Non-Clinical Business saw an increase
that was more than double the company's growth rate: sales were up
17.2% in 2017, from
¥1.68 billion to ¥1.97 billion.
Not all segments of Ina Research Incorporation experienced an increase in sales in 2017:
sales of Clinical Trial Business fell 90.9% to ¥13.57 million.